Finerenone across the proteinuric CKD spectrum
Blog - NephJC,
IntroductionThe prior NephJC discussion of finerenone versus spironolactone concluded that the comparative evidence base was…
IntroductionThe prior NephJC discussion of finerenone versus spironolactone concluded that the comparative evidence base was…
MONDAY, July 14, 2025 (HealthDay News) — Following priority review, the U.S. Food and Drug Administration approved Kerendia (fine…
New drugs and a growing awareness of the common condition offer hope for patients.
1. In this randomized controlled trial of patients with heart failure and mildly decreased or preserved ejection fraction…